Literature DB >> 2344161

Antimicrobial susceptibility of vancomycin-resistant Leuconostoc, Pediococcus, and Lactobacillus species.

J M Swenson1, R R Facklam, C Thornsberry.   

Abstract

Eighty-five strains of vancomycin-resistant gram-positive bacteria from three genera, Leuconostoc, Pediococcus, and Lactobacillus, were tested to determine susceptibility to 24 antimicrobial agents by broth microdilution and to 10 agents by disk diffusion. The MICs of vancomycin and teicoplanin ranged from 64 to greater than 512 micrograms/ml; however, the MICs of daptomycin, a new lipopeptide, were all less than or equal to 0.25 micrograms/ml. None of the organisms were resistant to imipenem, minocycline, chloramphenicol, gentamicin, or daptomycin. The MICs of penicillin were in the moderately susceptible range for all but three strains. Susceptibility to the other agents varied by genus and, in some cases, by species. When disk diffusion results were compared with MICs for drugs recommended for streptococci by the National Committee for Clinical Laboratory Standards, Villanova, Pa., few very major or major errors were obtained, but the number of minor errors was 19.3%. Therefore, we recommended that MIC testing be used instead of disk diffusion testing for these organisms.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2344161      PMCID: PMC171641          DOI: 10.1128/AAC.34.4.543

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

1.  Catheter-associated infection with a vancomycin-resistant gram-positive coccus of the Leuconostoc sp.

Authors:  S Hardy; K L Ruoff; E A Catlin; J Ignacio Santos
Journal:  Pediatr Infect Dis J       Date:  1988-07       Impact factor: 2.129

2.  Potential pathogenicity of Leuconostoc.

Authors:  Y M Coovadia; Z Solwa; J van Den Ende
Journal:  Lancet       Date:  1988-02-06       Impact factor: 79.321

3.  Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium.

Authors:  R Leclercq; E Derlot; J Duval; P Courvalin
Journal:  N Engl J Med       Date:  1988-07-21       Impact factor: 91.245

4.  In vitro activities of daptomycin and other antimicrobial agents against vancomycin-resistant gram-positive bacteria.

Authors:  L de la Maza; K L Ruoff; M J Ferraro
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

5.  Identification of gram-positive coccal and coccobacillary vancomycin-resistant bacteria.

Authors:  R Facklam; D Hollis; M D Collins
Journal:  J Clin Microbiol       Date:  1989-04       Impact factor: 5.948

6.  Vancomycin-resistant gram-positive bacteria isolated from human sources.

Authors:  K L Ruoff; D R Kuritzkes; J S Wolfson; M J Ferraro
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948

7.  Odontogenic infection secondary to Leuconostoc species.

Authors:  H S Wenocur; M A Smith; E M Vellozzi; J Shapiro; H D Isenberg
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

8.  Vancomycin resistance of clinical isolates of lactobacilli.

Authors:  R E Holliman; G P Bone
Journal:  J Infect       Date:  1988-05       Impact factor: 6.072

9.  Clinical laboratory challenges in the recognition of Leuconostoc spp.

Authors:  H D Isenberg; E M Vellozzi; J Shapiro; L G Rubin
Journal:  J Clin Microbiol       Date:  1988-03       Impact factor: 5.948

10.  Recovery of resistant enterococci during vancomycin prophylaxis.

Authors:  A H Kaplan; P H Gilligan; R R Facklam
Journal:  J Clin Microbiol       Date:  1988-06       Impact factor: 5.948

View more
  47 in total

1.  Lactobacillemia: an emerging cause of infection in both the immunocompromised and the immunocompetent host.

Authors:  S J Antony
Journal:  J Natl Med Assoc       Date:  2000-02       Impact factor: 1.798

2.  Characterization and antibiotic susceptibility of Pediococcus acidilactici strains isolated from neutropenic patients.

Authors:  J Maugein; P Crouzit; P Cony Makhoul; J Fourche
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-04       Impact factor: 3.267

3.  Pediococcus acidilactici endocarditis successfully treated with daptomycin.

Authors:  Peter C Iwen; Cezarina Mindru; Andre C Kalil; Diana F Florescu
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

4.  Lactobacillus masticator abscess after probiotics consumption.

Authors:  Vrinda Vyas; Sundus Mian; Kristopher Paolino; Zaid Siddique
Journal:  Proc (Bayl Univ Med Cent)       Date:  2020-09-28

5.  Evaluation of new broth media for microdilution antibiotic susceptibility testing of Lactobacilli, Pediococci, Lactococci, and Bifidobacteria.

Authors:  Ingo Klare; Carola Konstabel; Sibylle Müller-Bertling; Rolf Reissbrodt; Geert Huys; Marc Vancanneyt; Jean Swings; Herman Goossens; Wolfgang Witte
Journal:  Appl Environ Microbiol       Date:  2005-12       Impact factor: 4.792

6.  Effects of inoculum size and incubation time on broth microdilution susceptibility testing of lactic acid bacteria.

Authors:  Maria Egervärn; Hans Lindmark; Stefan Roos; Geert Huys; Sven Lindgren
Journal:  Antimicrob Agents Chemother       Date:  2006-10-23       Impact factor: 5.191

7.  Leuconostoc species endocarditis in an intravenous drug user.

Authors:  Damian Valencia; Victor Valencia; Adam Fershko
Journal:  J Cardiol Cases       Date:  2018-05-09

8.  Lactobacillus species identification, H2O2 production, and antibiotic resistance and correlation with human clinical status.

Authors:  A Felten; C Barreau; C Bizet; P H Lagrange; A Philippon
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

9.  Antimicrobial susceptibility of Pediococcus spp. and genetic basis of macrolide resistance in Pediococcus acidilactici HM3020.

Authors:  J Tankovic; R Leclercq; J Duval
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

10.  In vitro activities of ramoplanin, selected glycopeptides, fluoroquinolones, and other antibiotics against clinical bloodstream isolates of gram-positive cocci.

Authors:  T Lawrence; C Rotstein; T R Beam; E A Gorzynski; D Amsterdam
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.